Notably, P-tau181 concentration is the most accurate indicator for differentiating AD from non-AD dementia.372,373 While amyloid and tau PET and CSF biomarkers specifically indicate AD-related pathology, they are not entirely equivalent. Here, MAPT is linked to amyloidosis.